Richard Band

Richard Band

Richard Band is the author of Contrary Investing, in addition to numerous investment monographs. He has appeared on financial radio and TV and has been quoted in The Wall Street Journal, Business Week, Forbes and other leading publications. Richard graduated from Yale University, magna cum laude, and has been a respected investment commentator since 1982.

Recent Articles

Time to Update Microsoft, GE and More (MSFT, GE, DUK, PNY, ABBV)

Markets continue to reward stocks with strong earnings, and in some cases those making news. Here's an update on 5 stocks from both sides

INGN: A Breath of Fresh Air

This niche player has cornered the market in an important healthcare sector.

Wally’s Stunner Is No Reason to Leave Wal-Mart Stock (WMT)

WMT's recent earnings disappointment and forecast caught many by surprise, but Wal-Mart stock is still a long-term buy

Two-Way Traffic Again for Investors

With the recent rally starting to flatten out, it's time for investors to look at not only new buys, but also selling opportunities.

Bullish Dividends? Bearish Drama? Choose VNQ

If you would prefer to stop worrying about volatility, this REIT ETF is a great choice.

This Indicator Says Don’t Bail Out of the Market Too Soon

Tuesday's market pullback isn't a sign for investors to take out their money. In fact, one indicator suggests investors stay invested

ABBV: A Great Way to Play Healthcare’s Comeback

AbbVie's Humira is soon to be the world's No. 1 best-selling drug. And its growth prospects couldn't look better.

Time for Markets to Rally On — Maybe (ABBV, JNJ, MCD)

Several recent rallies in the markets have investors seeing positive signs moving forward, although doubts remain. Here is where I stand.

Kinder Morgan: KMI Is More than a Survivor Among Energy Stocks

Kinder Morgan is well positioned for the coming turnaround in energy -- and its dividend doesn't hurt either.

VIVAX: A Great Vanguard Fund for Long-Term Total Returns

If you're looking for rock-solid value stocks with some income, few funds do it better than Vanguard Value Index Fund (VIVAX).